The effect of oral zinc sulfate on the reduction of bilirubin level term jaundiced neonates during phototherapy
Phase 3
- Conditions
- eonatal Hyperbilirubinemia.Neonatal jaundice unspecified
- Registration Number
- IRCT201312067697N3
- Lead Sponsor
- Vice Chancellor for Research of Lorestan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 92
Inclusion Criteria
Term neonates; Gestational age of 37- 41 weeks; Birth weight more than 2500 grams; The minimum and maximum age of the infants between 3 - 28 days; Total bilirubin levels of Serum between 14 - 19 mg/dl; without any sign of abnormalities and diseases (infectious, metabolic, hemolytic, glucose-six-phosphate dehydrogenase deficiency, blood group incompatibility and positive coombs test). Exclusion criteria: The need for exchange transfusion and intensive care for more than 24 hours.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total bilirubin levels of serum. Timepoint: Before intervention, 24, 48, 72 and 96 hours after intervention. Method of measurement: Measurement of serum total bilirubin (diazo method).
- Secondary Outcome Measures
Name Time Method Duration of phototherapy. Timepoint: Daily. Method of measurement: Duration of phototherapy (days).